This study illustrates that where clinical trials are lacking, network meta-analysis can provide valuable insights into the potential clinical and economic benefits of value-based insurance design.
James D. Chambers, PhD, MPharm, MSc
Advertisement
Articles by James D. Chambers, PhD, MPharm, MSc
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Awareness Gaps Drive Narcolepsy, IH Delays: Logan Schneider, MD
2
Nephrologists Weigh Wins, Losses From 5 Years of Value-Based Kidney Care
3
Merck, Moderna Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%
4
Povetacicept Cuts Proteinuria by 52% in IgA Nephropathy at Week 36
5